Filing Flows › Bio Key International (BKYI) › Q2 2025
Bio Key International (BKYI) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 13, 2025
Bio Key International (BKYI) reported revenue of $1.7M for the second quarter 2025 (Q2 2025), +49% from a year earlier and +6% from the quarter before. Operating margin was -63.9%, net loss $1.2M (68.8% of revenue).
Bio Key International, Q2 2025: revenue $1.7M (+49% year over year), operating margin -63.9%, net loss $1.2M, operating cash flow −$880K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | +6% | +49% |
| Operating profit | −$1.1M | — | — |
| Net earnings | −$1.2M | — | — |
| Operating cash flow | −$880K | — | — |
What changed
Revenue was $1.7M in Q2 2025, up 49% year over year and up 6% from the previous quarter. License was the largest line at 48% of revenue. Hardware added $485K year over year (up 581%), 87% of the total change.
Gross margin was 72.6%, down 4.4 points from a year earlier. Operating costs exceeded revenue by $1.1M, an operating margin of -63.9%. Operating expenses fell 9% while revenue rose 49%. The quarter ended with a net loss of $1.2M, wider than the previous quarter's $737K loss.
Operating cash flow was −$880K. Non-cash charges added back $100K of depreciation and amortization and $22K of share-based compensation. Working capital and other items added $165K. Capital expenditures of $1K exceeded it, leaving free cash flow of −$881K.
Questions
What was Bio Key International's revenue in the second quarter 2025?
Bio Key International (BKYI) reported revenue of $1.7M for the second quarter 2025 (Q2 2025), +49% from a year earlier and +6% from the quarter before.
Was Bio Key International profitable in the second quarter 2025?
Operating loss was $1.1M (-63.9% of revenue) and net loss $1.2M.